Valeant - Company & Market Research Reports

Valeant Pharmaceuticals International is a specialty pharmaceutical and medical device company that manufactures a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International in September 2010. Valeant’s corporate headquarters are in Laval, Quebec, with U.S. headquarters in Bridgewater, N.J.

Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities - Product Thumbnail Image

Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities

  • Report
  • 144 Pages
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023 - Product Thumbnail Image

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

  • Report
  • 120 Pages
From
Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis - Product Thumbnail Image

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • Report
  • 136 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Global Cancer Vaccine Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trial Insight 2025

  • Clinical Trials
  • 700 Pages
From
Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition) - Product Thumbnail Image

Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition)

  • Report
  • 275 Pages
From
Provenge 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Provenge 2017 U.S. Promotional Audit Report

  • Report
  • 19 Pages
From
Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2017-2025 - Product Thumbnail Image

Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2017-2025

  • Report
  • 290 Pages
From
Global Topical Corticosteroids Market Analysis, Company Profiles, Size, Share, Growth, Trends and Forecast to 2024 - Product Thumbnail Image

Global Topical Corticosteroids Market Analysis, Company Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • Report
  • 355 Pages
From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • 91 Pages
From
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H2 2016 - Product Thumbnail Image

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 56 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
Global Cancer Vaccine Market & Clinical Trial Insight - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trial Insight

  • Clinical Trials
  • 750 Pages
From
Clindagel 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Clindagel 2017 U.S. Promotional Audit Report

  • Report
  • 17 Pages
From
Onexton 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Onexton 2017 U.S. Promotional Audit Report

  • Report
  • 19 Pages
From
Solodyn 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Solodyn 2017 U.S. Promotional Audit Report

  • Report
  • 17 Pages
From
Retin 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Retin 2017 U.S. Promotional Audit Report

  • Report
  • 17 Pages
From
Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • Report
From
Loading Indicator
adroll